Data accumulated in CURES[1] is available to appropriate state and federal agencies, law enforcement, and regulatory boards for disciplinary, civil, or criminal purposes. But when should CURES be reviewed for such purposes? When a government suspects overprescribing? May it be used against a prescriber or a pharmacist when no controlled substances are involved in the

Last week, I wrote about Walgreen’s settlement with state and federal governments for unlawfully soliciting Medicare and Medicaid beneficiaries to enroll in its Prescription Savings Club.

However, OIG has finalized a final rule extending safe harbors related to coupons, rebates, and other rewards from a retailer if:

  • The reward is offered on equal terms available

Last month, the DOJ and other state governments entered into a settlement with Walgreens. The company was accused of unlawfully soliciting Medicare and Medicaid recipients to enroll in its “Prescription Savings Club,” which gave discounts on thousands of brand and generic drugs as well as a 10% rebate on all Walgreens branded products including household

A very brief overview of California Administrative Discipline process.

The moment an inspector from a licensing board (Medical Board, Dental Board, Board of Pharmacy) comes to your healthcare business, it is important to understand and always keep in mind what such visit can lead to. I cannot stress enough how many times we could have